Status and phase
Conditions
Treatments
About
Study to determine the absorption of Nevirapine from different regions of the Gastro Intestinal tract.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
As a precaution, male subjects will be instructed to use appropriate barrier method contraception (e.g. condoms and spermicide) during the time interval between taking the first dose and three months following the last dose. Subjects will be advised to inform Pharmaceutical Profiles if their partner becomes pregnant within three months of them receiving the last dose of the study drug. Pharmaceutical Profiles will monitor the pregnancy to conclusion.
Primary purpose
Allocation
Interventional model
Masking
27 participants in 5 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal